• Image of NIKTIMVO medication Image of NIKTIMVO medication
    • NIKTIMVO

AXATILIMAB (AX a TIL i mab) treats graft versus host disease, a condition that can occur after a stem cell transplant. It is often prescribed when other treatment options have not worked well enough or cannot be tolerated. It works by decreasing inflammation. It also prevents the buildup of scar tissue. It is a monoclonal antibody.


There is no lifestyle interaction information available for this medication.